Elevation Oncology Inc (ELEV)
0.2615 +0.0015 (+0.58%) 10:58 ET [NASDAQ]
0.2600 x 100 0.2642 x 500
Realtime by (Cboe BZX)
0.2600 x 100 0.2642 x 500
Realtime 0.2600 unch (-) 09:12 ET
for Mon, Mar 31st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,485 | -45,704 | -95,080 | -32,039 | -17,265 |
| Depreciation Amortization | -1,426 | -823 | -184 | 18 | 15 |
| Accounts payable and accrued liabilities | 52 | -5,855 | 711 | -30 | 5,219 |
| Other Working Capital | 3,839 | -13,690 | 6,290 | 283 | 4,900 |
| Other Operating Activity | 5,656 | 9,892 | 2,780 | 1,601 | -5,167 |
| Operating Cash Flow | $-36,364 | $-56,180 | $-85,483 | $-30,167 | $-12,298 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,365 | 11,543 | -44,312 | N/A | N/A |
| PPE Investments | N/A | N/A | -86 | N/A | -71 |
| Investing Cash Flow | $-8,365 | $11,543 | $-44,398 | $N/A | $-71 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 30,000 | N/A | N/A |
| Common Stock Issued | 45,156 | 47,999 | 19 | 97,062 | 20 |
| Common Stock Repurchased | -48 | -24 | -35 | N/A | N/A |
| Other Financing Activity | -170 | 0 | -470 | -11 | 90,009 |
| Financing Cash Flow | $44,938 | $47,975 | $29,514 | $97,051 | $90,029 |
| Beginning Cash Position | 49,255 | 45,917 | 146,284 | 79,400 | 1,740 |
| End Cash Position | 49,464 | 49,255 | 45,917 | 146,284 | 79,400 |
| Net Cash Flow | $209 | $3,338 | $-100,367 | $66,884 | $77,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,364 | -56,180 | -85,483 | -30,167 | -12,298 |
| Capital Expenditure | N/A | N/A | -86 | N/A | -71 |
| Free Cash Flow | -36,364 | -56,180 | -85,569 | -30,167 | -12,369 |